Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. [electronic resource]
Producer: 20101206Description: 994-1006 p. digitalISSN:- 1940-6215
- Adenocarcinoma -- drug therapy
- Animals
- Biomarkers, Pharmacological -- analysis
- Biomarkers, Tumor -- analysis
- Cysteine -- analogs & derivatives
- Disease Models, Animal
- Male
- Metabolome -- drug effects
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Models, Biological
- Organoselenium Compounds -- pharmacokinetics
- Prostatic Neoplasms -- drug therapy
- Proteomics -- methods
- Selenium Compounds -- pharmacokinetics
- Selenocysteine -- analogs & derivatives
- Selenomethionine -- pharmacokinetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.